Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Lemaitre Vascular (LMAT – Research Report) today and set a price target of ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for the ...

Fortitude Family Office LLC purchased a new stake in Medtronic plc (NYSE:MDT – Free Report) during the third quarter, ...

Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...

Needham analyst Michael Matson has maintained their neutral stance on MDT stock, giving a Hold rating today. Michael Matson’s rating is ...

The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene ...

The company’s key products ... saw Medtronic increase its total revenue by 5.3% YoY. With its revenue sources spread relatively evenly among the Surgical, Neuroscience, and Cardiovascular ...

Medtronic PLC investors have been content with receiving dividends on their holdings for a few years now. The stock has ...